![Gavin MacBeath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gavin MacBeath
Directeur Général chez
TSCAN THERAPEUTICS, INC.
Fortune : 53 748 $ au 31/05/2026
Profil
Gavin MacBeath was the founder of Merrimack Pharmaceuticals, Inc., founded in 1993, where the title held was Head-Translational Medicine from 2016 to 2017.
Dr. MacBeath is currently Chief Executive Officer & Director at TScan Therapeutics, Inc. since 2023, with the job starting in 2018 and continuing.
Former jobs include Chief Scientific Officer at Abpro Corp.
from 2017 to 2018 and Associate Professor at Harvard University from 2002 to 2010.
Education includes a doctorate from The Scripps Research Institute conferred in 1997 and an undergraduate degree from the University of Manitoba conferred in 1991.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TSCAN THERAPEUTICS, INC. 0,08 % | 31/03/2026 | 49 767 ( 0,08 % ) | 53 748 $ | 31/05/2026 |
Postes actifs de Gavin MacBeath
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur Général | 28/03/2023 |
Anciens postes connus de Gavin MacBeath
| Sociétés | Poste | Fin |
|---|---|---|
| ABPRO CORPORATION | Directeur Technique/Scientifique/R&D | 01/07/2018 |
| MERRIMACK PHARMACEUTICALS | Fondateur | 01/09/2017 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2010 |
Formation de Gavin MacBeath
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Develops antibody therapies | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
